ABBV Options Signal Risk Below $210 as Traders Lock In Short-Term Puts and Calls

• ABBV is down nearly 3.5% today at $211.99, trading below its 30D moving average and key support levels.
• The options market is heavily skewed toward both calls and puts, with $240 calls and $200 puts leading in open interest.
• MACD and RSI hint at a fading momentum in the short-term bearish move, but a long-term range-bound pattern continues.

It’s been a tough morning for AbbVie — the stock is falling hard, down almost 3.5% as of this writing. And while the broader market isn’t screaming red, options traders are hedging both sides of the bet. Here’s what you need to know if you’re eyeing ABBV for a trade today.

Where the Options Are Pointing: Calls, Puts, and the Battle for Control

Let’s start with the options activity. For Friday’s expiration, the $240 call and $200 put are the most heavily traded, with open interest at 9635 and 4025 contracts, respectively. This tells us that some big money is positioning for either a sharp rebound or a meaningful drop — and they’re using this week’s options to do it.

The $220 call (OI: 1992) and $210 put (OI: 3611) also stand out. These strikes are just below current price levels, suggesting a defensive stance by traders who expect volatility to continue. If you look at the next Friday’s options, the $245 call is the most popular with 634 contracts, and the $210 put has 459 contracts open. It’s not just a short-term play — some are setting up for next week too.

Block trading is quiet today, so it’s mostly retail and institutional options players making the noise. But with this much open interest in both calls and puts, the message is clear: the market is preparing for a big move — either up or down.

No Major News — So Why the Jitters?

ABBV hasn’t seen any major news in the past few days. No earnings, no product updates, and no regulatory developments to speak of. That’s a big clue. When a stock drops hard with no headline triggers, it often reflects broader sentiment — fear of a pullback in the biotech sector, or maybe a rotation out of pharma names ahead of Fed action.

But here’s the twist: the options market isn’t just reacting to uncertainty — it’s pricing it in. With a put/call open interest ratio of just 0.986, there’s almost an equal bet on both sides. That kind of balance usually means indecision. But in a falling stock, it can also mean a rebound is coming — especially if the technicals show the move is overdone.

Actionable Traders’ Playbook for ABBV

If you’re looking to trade ABBV today, here are two setups that align with the options and technicals:

• Bull Put Spread for a Controlled Short Position:
• Buy the ABBV20260320P210 at a premium of ~$13.50 and sell the ABBV20260320P200 for ~$7.50. This creates a net cost of $6 and a max gain of $4 if ABBV closes below $200.
• It’s a low-risk way to bet on the downside — and the heavy open interest at $200 suggests smart money is already there.

• Call Buy for a Rebound Trade:
• If you believe the drop is overdone, consider the ABBV20260320C220 at ~$10.50. If ABBV bounces above its 200D MA at $214.95 and breaks the $220 level, this call could see a nice pop.
• A more conservative entry could be at $215–216. If it holds, you could go long ABBV and target a move up to $225 before fading it.

Volatility on the Horizon

ABBV is currently caught in a tight price range, and with the 200D MA at $214.95 and 30D MA at $226.61, it’s technically oversold. That means a rebound — or at least a stabilization — could be on the cards if this week’s options don’t play out as bearish as they seem. But if the $200–210 range breaks, we could see a more serious correction.

For traders, the key is to stay nimble. This week’s options are loaded with signals — and the best ones are the ones that line up with the price action. Right now, the market is hedging both sides, but the short-term trend remains bearish. Keep an eye on the 200D MA and the Bollinger Bands (currently at $218.49–$236.98). If the stock retests the $200 level, it could force a decision — either a breakdown or a rally.

ABBV isn’t screaming for help, but it’s definitely showing signs of stress. That’s where the opportunity lies — for those ready to act.